EpiEndo
140
Volume
+300%
Growth
regular
About the Topic
Icelandic clinical-stage pharmaceutical company founded in 2014, focusing on the impairment of epithelial barriers. EpiEndo Pharmaceuticals aims to address inflammatory conditions affecting the airway, gastrointestinal tract, and skin by targeting the underlying mechanisms of epithelial barrier dysfunction. The company's research and products are primarily intended for patients suffering from chronic inflammatory diseases.
EpiEndo was discovered on November 11th 2021 and it currently has a search volume of 140 with a growth of +300%.
Key Indicators
Growth
- Exploding
- Regular
- Peaked
Speed
- Exponential
- Constant
- Stationary
Seasonality
- High
- Medium
- Low
Volatility
- High
- Average
- Low
Members Only
Try Exploding Topics Pro
Get Free, Unlimited Access for 7 Days.
Categories
Save this topic and build your own trend dashboard.
Available with Exploding Topics Pro, try it now.
1.1M+ trends in our growing database.